Mrv1652310201622402D 18 19 0 0 1 0 999 V2000 2.8579 -4.1250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.1434 -3.7125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.1434 -2.8875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.8579 -2.4750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.5724 -2.8875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.5724 -3.7125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.8579 -1.6500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.5724 -1.2375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.2868 -1.6500 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 3.5724 -0.4125 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 4.2868 0.0000 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 4.2868 0.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.0013 1.2375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.7158 0.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 6.4302 1.2375 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 5.7158 0.0000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 5.0013 -0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.0013 -1.2375 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1 2 2 0 0 0 0 2 3 1 0 0 0 0 3 4 2 0 0 0 0 4 5 1 0 0 0 0 5 6 2 0 0 0 0 1 6 1 0 0 0 0 4 7 1 0 0 0 0 7 8 1 0 0 0 0 8 9 2 0 0 0 0 8 10 1 0 0 0 0 11 10 1 1 0 0 0 11 12 1 0 0 0 0 12 13 1 0 0 0 0 13 14 1 0 0 0 0 14 15 2 0 0 0 0 14 16 1 0 0 0 0 16 17 1 0 0 0 0 11 17 1 0 0 0 0 17 18 2 0 0 0 0 M END > DB11702 > drugbank > O=C(CC1=CC=CC=C1)N[C@H]1CCC(=O)NC1=O > InChI=1S/C13H14N2O3/c16-11-7-6-10(13(18)15-11)14-12(17)8-9-4-2-1-3-5-9/h1-5,10H,6-8H2,(H,14,17)(H,15,16,18)/t10-/m0/s1 > OQGRFQCUGLKSAV-JTQLQIEISA-N > C13H14N2O3 > 246.266 > 246.100442319 > 3 > 32 > 24.892423196820708 > 1 > 2 > 0 > 1 > N-[(3S)-2,6-dioxopiperidin-3-yl]-2-phenylacetamide > 0.37 > 0.12633580933333333 > -2.91 > 0 > 2 > 0 > 12.75025690862227 > 11.56479563314744 > -2.43080087195291 > 75.27000000000001 > 64.1978 > 3 > 1 > 3.04e-01 g/l > N-[(3S)-2,6-dioxopiperidin-3-yl]-2-phenylacetamide > 0 > DB11702 > investigational > Antineoplaston A10 > Antineoplaston A 10; ATENGENAL; BENZENEACETAMIDE, N-((3S)-2,6-DIOXO-3-PIPERIDINYL)-; BENZENEACETAMIDE, N-(2,6-DIOXO-3-PIPERIDINYL)-, (S)- $$$$